Defining Target Vancomycin Trough Concentrations for Treating Staphylococcus aureus Infection in Infants Aged 0 to 90 Days

This study analyzes data from a randomized clinical trial in infants 90 days and younger to develop a pharmacokinetic model to aid physicians in maintaining minimum inhibitory concentrations of vancomycin in young infants with Staphylococcus aureus infection.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Pediatr
Main Authors: Gwee, Amanda, Cranswick, Noel, McMullan, Brendan, Bolisetty, Srinivas, Hunt, Rodney W., Curtis, Nigel, Duffull, Stephen B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6563592/
https://ncbi.nlm.nih.gov/pubmed/31180478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2019.1488
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados